Stroke injury, cognitive impairment and vascular dementia

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 5, 2016, Pages 915-925

  Kalaria, Raj N ^a,b,c   Akinyemi, Rufus ^a,b,c   Ihara, Masafumi ^a,b,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Alzheimer's disease; Cognitive impairment; Dementia; Microinfarcts; Neuroimaging; Post stroke dementia; Stroke; Vascular dementia; White matter

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN INFARCTION; CELL DEATH; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEMENTIA; DIET RESTRICTION; DISEASE CLASSIFICATION; DISEASE COURSE; FUNCTIONAL NEUROIMAGING; GLOBAL ATROPHY; HUMAN; LIFESTYLE MODIFICATION; MEDIAL TEMPORAL LOBE; MEDIAL TEMPORAL LOBE ATROPHY; META ANALYSIS (TOPIC); MULTIINFARCT DEMENTIA; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); VASCULAR AMYLOIDOSIS; WHITE MATTER;

EID: 84961725735     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2016.01.015     Document Type: Article

References (160)

1. Rothwell P.M., Algra A., Amarenco P. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet 2011, 377:1681-1692.
2. Feigin V.L., Lawes C.M., Bennett D.A., Barker-Collo S.L., Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009, 8:355-369.
3. Krishnamurthi R.V., Feigin V.L., Forouzanfar M.H., Mensah G.A., Connor M., Bennett D.A., Moran A.E., Sacco R.L., Anderson L.M., Truelsen T., O'Donnell M., Venketasubramanian N., Barker-Collo S., Lawes C.M., Wang W., Shinohara Y., Witt E., Ezzati M., Naghavi M., Murray C., I.R.F.S.Global Burden of Diseases, G.B.D.S.E.Group Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Global Health 2013, 1:e259-e281.
4. Lee S., Shafe A.C., Cowie M.R. UK stroke incidence, mortality and cardiovascular risk management 1999-2008: time-trend analysis from the General Practice Research database. BMJ Open 2011, 1.
5. Connor M.D., Walker R., Modi G., Warlow C.P. Burden of stroke in black populations in sub-Saharan Africa. Lancet Neurol. 2007, 6:269-278.
6. Rothwell P.M., Coull A.J., Giles M.F., Howard S.C., Silver L.E., Bull L.M., Gutnikov S.A., Edwards P., Mant D., Sackley C.M., Farmer A., Sandercock P.A., Dennis M.S., Warlow C.P., Bamford J.M., Anslow P. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004, 363:1925-1933.
7. Seshadri S., Wolf P.A. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurol. 2007, 6:1106-1114.
8. Rothwell P.M., Coull A.J., Silver L.E., Fairhead J.F., Giles M.F., Lovelock C.E., Redgrave J.N., Bull L.M., Welch S.J., Cuthbertson F.C., Binney L.E., Gutnikov S.A., Anslow P., Banning A.P., Mant D., Mehta Z., Oxford Vascular S. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005, 366:1773-1783.
9. O'Donnell M.J., Xavier D., Liu L., Zhang H., Chin S.L., Rao-Melacini P., Rangarajan S., Islam S., Pais P., McQueen M.J., Mondo C., Damasceno A., Lopez-Jaramillo P., Hankey G.J., Dans A.L., Yusoff K., Truelsen T., Diener H.C., Sacco R.L., Ryglewicz D., Czlonkowska A., Weimar C., Wang X., Yusuf S., I.investigators Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010, 376:112-123.
10. Sacco R.L., Kasner S.E., Broderick J.P., Caplan L.R., Connors J.J., Culebras A., Elkind M.S., George M.G., Hamdan A.D., Higashida R.T., Hoh B.L., Janis L.S., Kase C.S., Kleindorfer D.O., Lee J.M., Moseley M.E., Peterson E.D., Turan T.N., Valderrama A.L., Vinters H.V., C.o.C.S.American Heart Association Stroke Council, Anesthesia, R.Council on Cardiovascular, Intervention, C.Council on, N.Stroke, E.Council on, Prevention, D.Council on Peripheral Vascular, P.A.Council on Nutrition, Metabolism An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013, 44:2064-2089.
11. Sacco R.L., Ellenberg J.H., Mohr J.P., Tatemichi T.K., Hier D.B., Price T.R., Wolf P.A. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann. Neurol. 1989, 25:382-390.
12. Zheng L., Vinters H.V., Mack W.J., Zarow C., Ellis W.G., Chui H.C. Cerebral atherosclerosis is associated with cystic infarcts and microinfarcts but not Alzheimer pathologic changes. Stroke 2013, 44:2835-2841.
13. Amarenco P., Bogousslavsky J., Caplan L.R., Donnan G.A., Hennerici M.G. New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc. Dis. 2009, 27:502-508.
14. Amarenco P., Bogousslavsky J., Caplan L.R., Donnan G.A., Hennerici M.G. Classification of stroke subtypes. Cerebrovasc. Dis. 2009, 27:493-501.
15. Kalaria R.N., Perry R.H., O'Brien J., Jaros E. Atheromatous disease in small intracerebral vessels, microinfarcts and dementia. Neuropathol. Appl. Neurobiol. 2012, 38:505-508.
16. Bevan S., Traylor M., Adib-Samii P., Malik R., Paul N.L., Jackson C., Farrall M., Rothwell P.M., Sudlow C., Dichgans M., Markus H.S. Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke 2012, 43:3161-3167.
17. Pasi M., Poggesi A., Salvadori E., Pantoni L. Post-stroke dementia and cognitive impairment. Front. Neurol. Neurosci. 2012, 30:65-69.
18. Bejot Y., Jacquin A., Rouaud O., Durier J., Aboa-Eboule C., Hervieu M., Osseby G.V., Giroud M. One-year survival of demented stroke patients: data from the Dijon Stroke Registry, France (1985-2008). Eur. J. Neurol. 2012, 19:712-717.
19. Leys D., Henon H., Mackowiak-Cordoliani M.A., Pasquier F. Poststroke dementia. Lancet Neurol. 2005, 4:752-759.
20. Altieri M., Di Piero V., Pasquini M., Gasparini M., Vanacore N., Vicenzini E., Lenzi G.L. Delayed poststroke dementia: a 4-year follow-up study. Neurology 2004, 62:2193-2197.
21. Allan L.M., Rowan E.N., Firbank M.J., Thomas A.J., Parry S.W., Polvikoski T.M., O'Brien J.T., Kalaria R.N. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain J. Neurol. 2012, 134:3716-3727.
22. Hachinski V., Iadecola C., Petersen R.C., Breteler M.M., Nyenhuis D.L., Black S.E., Powers W.J., DeCarli C., Merino J.G., Kalaria R.N., Vinters H.V., Holtzman D.M., Rosenberg G.A., Dichgans M., Marler J.R., Leblanc G.G. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006, 37:2220-2241.
23. Gorelick P.B., Scuteri A., Black S.E., Decarli C., Greenberg S.M., Iadecola C., Launer L.J., Laurent S., lopez O.L., Nyenhuis D., Petersen R.C., Schneider J.A., Tzourio C., Arnett D.K., Bennett D.A., Chui H.C., Higashida R.T., Lindquist R., Nilsson P.M., Roman G.C., Sellke F.W., Seshadri S., C.o.E.American Heart Association Stroke Council, C.o.C.N.C.o.C.R.Prevention, Intervention, S.Council on Cardiovascular, Anesthesia Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 2011, 42:2672-2713.
24. Sachdev P., Kalaria R., O'Brien J., Skoog I., Alladi S., Black S.E., Blacker D., Blazer D.G., Chen C., Chui H., Ganguli M., Jellinger K., Jeste D.V., Pasquier F., Paulsen J., Prins N., Rockwood K., Roman G., Scheltens P. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis. Assoc. Disord. 2014.
25. Onyike C.U. Cerebrovascular disease and dementia. Int. Rev. Psychiatry 2006, 18:423-431.
26. Vataja R., Pohjasvaara T., Mantyla R., Ylikoski R., Leppavuori A., Leskela M., Kalska H., Hietanen M., Aronen H.J., Salonen O., Kaste M., Erkinjuntti T. MRI correlates of executive dysfunction in patients with ischaemic stroke. Eur. J. Neurol. 2003, 10:625-631.
27. Kandiah N., Wiryasaputra L., Narasimhalu K., Karandikar A., Marmin M., Chua E.V., Sitoh Y.Y. Frontal subcortical ischemia is crucial for post stroke cognitive impairment. J. Neurol. Sci. 2011, 309:92-95.
28. Stephens S., Kenny R.A., Rowan E., Allan L., Kalaria R.N., Bradbury M., Ballard C.G. Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke. Int. J. Geriatr. Psychiatry 2004, 19:1053-1057.
29. Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., Amaducci L., Orgogozo J.M., Brun A., Hofman A., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993, 43:250-260.
30. Schnider A., Regard M., Landis T. Anterograde and retrograde amnesia following bitemporal infarction. Behav. Neurol. 1994, 7:87-92.
31. Pantoni L., Basile A.M., Romanelli M., Piccini C., Sarti C., Nencini P., Inzitari D. Abulia and cognitive impairment in two patients with capsular genu infarct. Acta Neurol. Scand. 2001, 104:185-190.
32. Melkas S., Vataja R., Oksala N.K., Jokinen H., Pohjasvaara T., Oksala A., Leppavuori A., Kaste M., Karhunen P.J., Erkinjuntti T. Depression-executive dysfunction syndrome relates to poor poststroke survival. Am. J. Geriatr.Psychiatry 2010, 18:1007-1016.
33. Allan L.M., Rowan E.N., Thomas A.J., Polvikoski T.M., O'Brien J.T., Kalaria R.N. Long-term incidence of depression and predictors of depressive symptoms in older stroke survivors. Br. J. Psychiatry J. Ment. Sci. 2013, 203:453-460.
34. Liu W., Wong A., Au L., Yang J., Wang Z., Leung E.Y., Chen S., Ho C.L., Mok V.C. Influence of amyloid-beta on cognitive decline after stroke/transient ischemic attack: three-year longitudinal study. Stroke 2015, 46:3074-3080.
35. de Koning I., van Kooten F., Koudstaal P.J., Dippel D.W. Diagnostic value of the Rotterdam-CAMCOG in post-stroke dementia. J. Neurol. Neurosurg. Psychiatry 2005, 76:263-265.
36. Pendlebury S.T., Cuthbertson F.C., Welch S.J., Mehta Z., Rothwell P.M. Underestimation of cognitive impairment by mini-mental state examination versus the Montreal cognitive assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke 2010, 41:1290-1293.
37. Dong Y., Sharma V.K., Chan B.P., Venketasubramanian N., Teoh H.L., Seet R.C., Tanicala S., Chan Y.H., Chen C. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J. Neurol. Sci. 2010, 299:15-18.
38. Salvadori E., Pasi M., Poggesi A., Chiti G., Inzitari D., Pantoni L. Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment. J. Neurol. 2013, 260:2220-2227.
39. Akinyemi R.O., Allan L., Owolabi M.O., Akinyemi J.O., Ogbole G., Ajani A., Firbank M., Ogunniyi A., Kalaria R.N. Profile and determinants of vascular cognitive impairment in African stroke survivors: the CogFAST Nigeria study. J. Neurol. Sci. 2014, 346:241-249.
40. Vinters H.V., Ellis W.G., Zarow C., Zaias B.W., Jagust W.J., Mack W.J., Chui H.C. Neuropathologic substrates of ischemic vascular dementia. J. Neuropathol. Exp. Neurol. 2000, 59:931-945.
41. Kalaria R.N., Kenny R.A., Ballard C.G., Perry R., Ince P., Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J. Neurol. Sci. 2004, 226:75-80.
42. Yang J., Wong A., Wang Z., Liu W., Au L., Xiong Y., Chu W.W., Leung E.Y., Chen S., Lau C., Chan A.Y., Lau A.Y., Fan F., Ip V., Soo Y., Leung T., Ho C.L., Wong L.K., Mok V.C. Risk factors for incident dementia after stroke and transient ischemic attack. Alzheimers Dement. 2014.
43. Kokmen E., Whisnant J.P., O'Fallon W.M., Chu C.P., Beard C.M. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology 1996, 46:154-159.
44. Pendlebury S.T. Stroke-related dementia: rates, risk factors and implications for future research. Maturitas 2009, 64:165-171.
45. Pendlebury S.T., Rothwell P.M. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009, 8:1006-1018.
46. Kalaria R.N., Mukaetova-Ladinska E.B. Delirium, dementia and senility. Brain J. Neurol. 2012, 135:2582-2584.
47. Melkas S., Laurila J.V., Vataja R., Oksala N., Jokinen H., Pohjasvaara T., Leppavuori A., Kaste M., Karhunen P.J., Erkinjuntti T. Post-stroke delirium in relation to dementia and long-term mortality. Int. J. Geriatr. Psychiatry 2012, 27:401-408.
48. Jacova C., Pearce L.A., Costello R., McClure L.A., Holliday S.L., Hart R.G., Benavente O.R. Cognitive impairment in lacunar strokes: the SPS3 trial. Ann. Neurol. 2012, 72:351-362.
49. Kase C.S., Wolf P.A., Kelly-Hayes M., Kannel W.B., Beiser A., D'Agostino R.B. Intellectual decline after stroke: the Framingham Study. Stroke 1998, 29:805-812.
50. Prencipe M., Ferretti C., Casini A.R., Santini M., Giubilei F., Culasso F. Stroke, disability, and dementia: results of a population survey. Stroke 1997, 28:531-536.
51. Ballard C., Rowan E., Stephens S., Kalaria R., Kenny R.A. Prospective follow-up study between 3 and 15 months after stroke: improvements and decline in cognitive function among dementia-free stroke survivors >75 years of age. Stroke 2003, 34:2440-2444.
52. Barba R., Martinez-Espinosa S., Rodriguez-Garcia E., Pondal M., Vivancos J., Del Ser T. Poststroke dementia: clinical features and risk factors. Stroke 2000, 31:1494-1501.
53. Pohjasvaara T., Erkinjuntti T., Ylikoski R., Hietanen M., Vataja R., Kaste M. Clinical determinants of poststroke dementia. Stroke 1998, 29:75-81.
54. Tatemichi T.K., Desmond D.W., Mayeux R., Paik M., Stern Y., Sano M., Remien R.H., Williams J.B., Mohr J.P., Hauser W.A., et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992, 42:1185-1193.
55. Jokinen H., Melkas S., Ylikoski R., Pohjasvaara T., Kaste M., Erkinjuntti T., Hietanen M. Post-stroke cognitive impairment is common even after successful clinical recovery 2015, 22:1288-1294.
56. Pendlebury S.T., Rothwell P.M. Risk of recurrent stroke, other vascular events and dementia after transient ischaemic attack and stroke. Cerebrovasc. Dis. 2009, 27(Suppl. 3):1-11.
57. Akinyemi R.O., Firbank M., Ogbole G.I., Allan L.M., Owolabi M.O., Akinyemi J.O., Yusuf B.P., Ogunseyinde O., Ogunniyi A., Kalaria R.N. Medial temporal lobe atrophy, white matter hyperintensities and cognitive impairment among Nigerian African stroke survivors. BMC Res. Notes 2015, 8:625.
58. Song J., Lee W.T., Park K.A., Lee J.E. Association between risk factors for vascular dementia and adiponectin. BioMed Res. Int. 2014, 2014:261672.
59. Moroney J.T., Bagiella E., Desmond D.W., Paik M.C., Stern Y., Tatemichi T.K. Risk factors for incident dementia after stroke. Role of hypoxic and ischemic disorders. Stroke 1996, 27:1283-1289.
60. Rowan E., Morris C.M., Stephens S., Ballard C., Dickinson H., Rao H., Saxby B.K., McLaren A.T., Kalaria R.N., Kenny R.A. Impact of hypertension and apolipoprotein E4 on poststroke cognition in subjects >75 years of age. Stroke 2005, 36:1864-1868.
61. Savva G.M., Stephan B.C., G.Alzheimer's Society Vascular Dementia Systematic Review Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 2010, 41:e41-e46.
62. Panza F., Solfrizzi V., Logroscino G., Maggi S., Santamato A., Seripa D., Pilotto A. Current epidemiological approaches to the metabolic-cognitive syndrome. J. Alzheimers Dis. 2012, 30(Suppl. 2):S31-S75.
63. Bejot Y., Aboa-Eboule C., Durier J., Rouaud O., Jacquin A., Ponavoy E., Richard D., Moreau T., Giroud M. Prevalence of early dementia after first-ever stroke: a 24-year population-based study. Stroke 2011, 42:607-612.
64. Censori B., Manara O., Agostinis C., Camerlingo M., Casto L., Galavotti B., Partziguian T., Servalli M.C., Cesana B., Belloni G., Mamoli A. Dementia after first stroke. Stroke 1996, 27:1205-1210.
65. Inzitari D., Di Carlo A., Pracucci G., Lamassa M., Vanni P., Romanelli M., Spolveri S., Adriani P., Meucci I., Landini G., Ghetti A. Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based stroke registry. Stroke 1998, 29:2087-2093.
66. Reitz C., Bos M.J., Hofman A., Koudstaal P.J., Breteler M.M. Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study. Stroke 2008, 39:36-41.
67. Gamaldo A., Moghekar A., Kilada S., Resnick S.M., Zonderman A.B., O'Brien R. Effect of a clinical stroke on the risk of dementia in a prospective cohort. Neurology 2006, 67:1363-1369.
68. Schrijvers E.M., Schurmann B., Koudstaal P.J., van den Bussche H., Van Duijn C.M., Hentschel F., Heun R., Hofman A., Jessen F., Kolsch H., Kornhuber J., Peters O., Rivadeneira F., Ruther E., Uitterlinden A.G., Riedel-Heller S., Dichgans M., Wiltfang J., Maier W., Breteler M.M., Ikram M.A. Genome-wide association study of vascular dementia. Stroke 2012, 43:315-319.
69. Arpa A., del Ser T., Goda G., Barba R., Bornstein B. Apolipoprotein E, angiotensin-converting enzyme and alpha-1-antichymotrypsin genotypes are not associated with post-stroke dementia. J. Neurol. Sci. 2003, 210:77-82.
70. Klimkowicz A., Slowik A., Dziedzic T., Polczyk R., Szczudlik A. Post-stroke dementia is associated with alpha(1)-antichymotrypsin polymorphism. J. Neurol. Sci. 2005, 234:31-36.
71. Skoog I., Hesse C., Aevarsson O., Landahl S., Wahlstrom J., Fredman P., Blennow K. A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J. Neurol. Neurosurg. Psychiatry 1998, 64:37-43.
72. Slooter A.J., Tang M.X., van Duijn C.M., Stern Y., Ott A., Bell K., Breteler M.M., Van Broeckhoven C., Tatemichi T.K., Tycko B., Hofman A., Mayeux R. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. JAMA 1997, 277:818-821.
73. Ballard C.G., Morris C.M., Rao H., O'Brien J.T., Barber R., Stephens S., Rowan E., Gibson A., Kalaria R.N., Kenny R.A. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment. Neurology 2004, 63:1399-1402.
74. Markus H.S., Bevan S. Mechanisms and treatment of ischaemic stroke-insights from genetic associations. Nat. Rev. Neurol. 2014, 10:723-730.
75. Yamamoto Y., Craggs L., Baumann M., Kalimo H., Kalaria R.N. Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol. Appl. Neurobiol. 2011, 37:94-113.
76. Schmidt H., Zeginigg M., Wiltgen M., Freudenberger P., Petrovic K., Cavalieri M., Gider P., Enzinger C., Fornage M., Debette S., Rotter J.I., Ikram M.A., Launer L.J., Schmidt R., C.c.N.w.group Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease. Brain J. Neurol. 2011, 134:3384-3397.
77. Verdura E., Herve D., Scharrer E., Amador Mdel M., Guyant-Marechal L., Philippi A., Corlobe A., Bergametti F., Gazal S., Prieto-Morin C., Beaufort N., Le Bail B., Viakhireva I., Dichgans M., Chabriat H., Haffner C., Tournier-Lasserve E. Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease. Brain J. Neurol. 2015, 138:2347-2358.
78. Rannikmae K., Davies G., Thomson P.A., Bevan S., Devan W.J., Falcone G.J., Traylor M., Anderson C.D., Battey T.W., Radmanesh F., Deka R., Woo J.G., Martin L.J., Jimenez-Conde J., Selim M., Brown D.L., Silliman S.L., Kidwell C.S., Montaner J., Langefeld C.D., Slowik A., Hansen B.M., Lindgren A.G., Meschia J.F., Fornage M., Bis J.C., Debette S., Ikram M.A., Longstreth W.T., Schmidt R., Zhang C.R., Yang Q., Sharma P., Kittner S.J., Mitchell B.D., Holliday E.G., Levi C.R., Attia J., Rothwell P.M., Poole D.L., Boncoraglio G.B., Psaty B.M., Malik R., Rost N., Worrall B.B., Dichgans M., Agtmael T.Van, Woo D., Markus H.S., Seshadri S., Rosand J., Sudlow C.L., Consortium M., C.W.Group, C.International Stroke Genetics Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease. Neurology 2015, 84:918-926. I.I.G.S. Collaboration, W.M.H.i.I.S.G.S. CollaborationW.M.H.i.I.S.G.S. Collaboration.
79. Pohjasvaara T., Mantyla R., Salonen O., Aronen H.J., Ylikoski R., Hietanen M., Kaste M., Erkinjuntti T. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch. Neurol. 2000, 57:1295-1300.
80. Chaudhari T.S., Verma R., Garg R.K., Singh M.K., Malhotra H.S., Sharma P.K. Clinico-radiological predictors of vascular cognitive impairment (VCI) in patients with stroke: a prospective observational study. J. Neurol. Sci. 2014, 340:150-158.
81. Jacquin A., Binquet C., Rouaud O., Graule-Petot A., Daubail B., Osseby G.V., Bonithon-Kopp C., Giroud M., Bejot Y. Post-stroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke. J. Alzheimers Dis. 2014, 40:1029-1038.
82. Ihle-Hansen H., Thommessen B., Wyller T.B., Engedal K., Oksengard A.R., Stenset V., Loken K., Aaberg M., Fure B. Incidence and subtypes of MCI and dementia 1 year after first-ever stroke in patients without pre-existing cognitive impairment. Dement. Geriatr. Cogn. Disord. 2011, 32:401-407.
83. Brodaty H., Liu Z., Withall A., Sachdev P.S. The longitudinal course of post-stroke apathy over five years. J. Neuropsychiatr. Clin. Neurosci. 2013, 25:283-291.
84. Park J.H., Kim B.J., Bae H.J., Lee J., Lee J., Han M.K., K.Y.O, Park S.H., Kang Y., Yu K.H., Lee B.C. Impact of post-stroke cognitive impairment with no dementia on health-related quality of life. J. Stroke 2013, 15:49-56..
85. Firbank M.J., Burton E.J., Barber R., Stephens S., Kenny R.A., Ballard C., Kalaria R.N., O'Brien J.T. Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol. Aging 2007, 28:1664-1669.
86. Firbank M.J., Allan L.M., Burton E.J., Barber R., O'Brien J.T., Kalaria R.N. Neuroimaging predictors of death and dementia in a cohort of older stroke survivors. J. Neurol. Neurosurg. Psychiatry 2012, 83:263-267.
87. Duering M., Righart R., Csanadi E., Jouvent E., Herve D., Chabriat H., Dichgans M. Incident subcortical infarcts induce focal thinning in connected cortical regions. Neurology 2012, 79:2025-2028.
88. Xiong Y., Wong A., Wong K., Chu W.C., Hu X., Chen X., Wong K.S., Wong S.T., Liu X., Mok V. Predictors for cortical gray matter volume in stroke patients with confluent white matter changes. J. Neurol. Sci. 2014, 338:169-173.
89. Brouns R., De Deyn P.P. The complexity of neurobiological processes in acute ischemic stroke. Clin. Neurol. Neurosurg. 2009, 111:483-495.
90. Rami A., Kogel D. Apoptosis meets autophagy-like cell death in the ischemic penumbra: two sides of the same coin?. Autophagy 2008, 4:422-426.
91. Koike M., Shibata M., Tadakoshi M., Gotoh K., Komatsu M., Waguri S., Kawahara N., Kuida K., Nagata S., Kominami E., Tanaka K., Uchiyama Y. Inhibition of autophagy prevents hippocampal pyramidal neuron death after hypoxic-ischemic injury. Am. J. Pathol. 2008, 172:454-469.
92. Adhami F., Schloemer A., Kuan C.Y. The roles of autophagy in cerebral ischemia. Autophagy 2007, 3:42-44.
93. Smith C.M., Chen Y., Sullivan M.L., Kochanek P.M., Clark R.S. Autophagy in acute brain injury: feast, famine, or folly?. Neurobiol. Dis. 2010, 43:52-59.
94. McColl B.W., Allan S.M., Rothwell N.J. Systemic inflammation and stroke: aetiology, pathology and targets for therapy. Biochem. Soc. Trans. 2007, 35:1163-1165.
95. Meisel C., Meisel A. Suppressing immunosuppression after stroke. N. Engl. J. Med. 2011, 365:2134-2136.
96. Gold A.B., Herrmann N., Swardfager W., Black S.E., Aviv R.I., Tennen G., Kiss A., Lanctot K.L. The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment. J. Neuroinflammation 2011, 8:17.
97. Swardfager W., Winer D.A., Herrmann N., Winer S., Lanctot K.L. Interleukin-17 in post-stroke neurodegeneration. Neurosci. Biobehav. Rev. 2013, 37:436-447.
98. Chen A., Oakley A.E., Monteiro M., Tuomela K., Allan L.M., Mukaetova-Ladinska E.B., O'Brien J.T., Kalaria R.N. Multiplex analyte assays to characterise different dementias: brain inflammatory cytokines in post-stroke and other dementias. Neurobiol. Aging 2016, 38:56-67.
99. Foster V., Oakley A.E., Slade J.Y., Hall R., Polvikoski T.M., Burke M., Thomas A.J., Khundakar A., Allan L.M., Kalaria R.N. Pyramidal neurons of the prefrontal cortex in post-stroke, vascular and other ageing-related dementias. Brain J. Neurol. 2014, 137:2509-2521.
100. Duering M., Righart R., Wollenweber F.A., Zietemann V., Gesierich B., Dichgans M. Acute infarcts cause focal thinning in remote cortex via degeneration of connecting fiber tracts. Neurology 2015, 84:1685-1692.
101. Simpson J.E., Fernando M.S., Clark L., Ince P.G., Matthews F., Forster G., O'Brien J.T., Barber R., Kalaria R.N., Brayne C., Shaw P.J., Lewis C.E., Wharton S.B. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol. Appl. Neurobiol. 2007, 33:410-419.
102. Sachdev P.S., Chen X., Joscelyne A., Wen W., Altendorf A., Brodaty H. Hippocampal size and dementia in stroke patients: the Sydney stroke study. J. Neurol. Sci. 2007, 260:71-77.
103. Burton E.J., Kenny R.A., O'Brien J., Stephens S., Bradbury M., Rowan E., Kalaria R., Firbank M., Wesnes K., Ballard C. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke 2004, 35:1270-1275.
104. Akiguchi I., Tomimoto H., Wakita H., Kawamoto Y., Matsuo A., Ohnishi K., Watanabe T., Budka H. Topographical and cytopathological lesion analysis of the white matter in Binswanger's disease brains. Acta Neuropathol. 2004, 107:563-570.
105. Ihara M., Tomimoto H., Ishizu K., Mukai T., Yoshida H., Sawamoto N., Inoue M., Doi T., Hashikawa K., Konishi J., Shibasaki H., Fukuyama H. Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: a positron emission tomography study. Stroke 2004, 35:942-947.
106. Fernando M.S., Simpson J.E., Matthews F., Brayne C., Lewis C.E., Barber R., Kalaria R.N., Forster G., Esteves F., Wharton S.B., Shaw P.J., O'Brien J.T., Ince P.G. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 2006, 37:1391-1398.
107. Polvikoski T.M., van Straaten E.C., Barkhof F., Sulkava R., Aronen H.J., Niinisto L., Oinas M., Scheltens P., Erkinjuntti T., Kalaria R.N. Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. Neurology 2010, 75:2071-2078.
108. Ihara M., Polvikoski T.M., Hall R., Slade J.Y., Perry R.H., Oakley A.E., Englund E., O'Brien J.T., Ince P.G., Kalaria R.N. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol. 2010, 119:579-589.
109. Jokinen H., Schmidt R., Ropele S., Fazekas F., Gouw A.A., Barkhof F., Scheltens P., Madureira S., Verdelho A., Ferro J.M., Wallin A., Poggesi A., Inzitari D., Pantoni L., Erkinjuntti T., Group L.S. Diffusion changes predict cognitive and functional outcome: the LADIS study. Ann. Neurol. 2013, 73:576-583.
110. Duering M., Csanadi E., Gesierich B., Jouvent E., Herve D., Seiler S., Belaroussi B., Ropele S., Schmidt R., Chabriat H., Dichgans M. Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease. Brain J. Neurol. 2013, 136:2717-2726.
111. Chen A., Akinyemi R., Hase Y., Firbank M., Ndung'u M., Washida K., Okamoto Y., Foster V., Craggs L., Polvikoski T.M., Thomas A., Allan L.M., Oakley A., O'Brien J.T., Horsburgh K., Ihara M., Kalaria R.N. Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia. Brain 2016, 139:242-258.
112. Firbank M.J., He J., Blamire A.M., Singh B., Danson P., Kalaria R.N., O'Brien J.T. Cerebral blood flow by arterial spin labeling in poststroke dementia. Neurology 2011, 76:1478-1484.
113. Kim B.J., Oh M.Y., Jang M.S., Han M.K., Lee J., Lee J., Kang Y., Yu K.H., Lee B.C., Kim S., Yoon B.W., Bae H.J. Medial temporal atrophy and memory dysfunction in poststroke cognitive impairment-no dementia. J. Clin. Neurol. 2012, 8:43-50.
114. Snaphaan L., Rijpkema M., van Uden I., Fernandez G., de Leeuw F.E. Reduced medial temporal lobe functionality in stroke patients: a functional magnetic resonance imaging study. Brain J. Neurol. 2009, 132:1882-1888.
115. de Leeuw F.E., Barkhof F., Scheltens P. White matter lesions and hippocampal atrophy in Alzheimer's disease. Neurology 2004, 62:310-312.
116. Gemmell E., Bosomworth H., Allan L., Hall R., Khundakar A., Oakley A.E., Deramecourt V., Polvikoski T.M., O'Brien J.T., Kalaria R.N. Hippocampal neuronal atrophy and cognitive function in delayed poststroke and aging-related dementias. Stroke 2012, 43:808-814.
117. Nishio K., Ihara M., Yamasaki N., Kalaria R.N., Maki T., Fujita Y., Ito H., Oishi N., Fukuyama H., Miyakawa T., Takahashi R., Tomimoto H. A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke 2010, 41:1278-1284.
118. Boon A., Lodder J., Heuts-van Raak L., Kessels F. Silent brain infarcts in 755 consecutive patients with a first-ever supratentorial ischemic stroke. Relationship with index-stroke subtype, vascular risk factors, and mortality. Stroke 1994, 25:2384-2390.
119. Mok V.C., Wong A., Lam W.W., Fan Y.H., Tang W.K., Kwok T., Hui A.C., Wong K.S. Cognitive impairment and functional outcome after stroke associated with small vessel disease. J. Neurol. Neurosurg. Psychiatry 2004, 75:560-566.
120. Corea F., Henon H., Pasquier F., Leys D. Silent infarcts in stroke patients: patient characteristics and effect on 2-year outcome. J. Neurol. 2001, 248:271-278.
121. Tanskanen M., Kalaria R.N., Notkola I.L., Makela M., Polvikoski T., Myllykangas L., Sulkava R., Kalimo H., Paetau A., Scheltens P., Barkhof F., van Straaten E., Erkinjuntti T. Relationships between white matter hyperintensities, cerebral amyloid angiopathy and dementia in a population-based sample of the oldest old. Curr. Alzheimer Res. 2013, 10:1090-1097.
122. Charidimou A., Gang Q., Werring D.J. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J. Neurol. Neurosurg. Psychiatry 2012, 83:124-137.
123. Viswanathan A., Greenberg S.M. Cerebral amyloid angiopathy in the elderly. Ann. Neurol. 2011, 70:871-880.
124. Smith E.E., Schneider J.A., Wardlaw J.M., Greenberg S.M. Cerebral microinfarcts: the invisible lesions. Lancet Neurol. 2012, 11:272-282.
125. Okamoto Y., Ihara M., Fujita Y., Ito H., Takahashi R., Tomimoto H. Cortical microinfarcts in Alzheimer's disease and subcortical vascular dementia. Neuroreport 2009, 20:990-996.
126. Kovari E., Gold G., Herrmann F.R., Canuto A., Hof P.R., Michel J.P., Bouras C., Giannakopoulos P. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 2004, 35:410-414.
127. Van der Flier W.M., Cordonnier C. Microbleeds in vascular dementia: clinical aspects. Exp. Gerontol. 2012, 47:853-857.
128. Cordonnier C., van der Flier W.M., Sluimer J.D., Leys D., Barkhof F., Scheltens P. Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2006, 66:1356-1360.
129. Haglund M., Passant U., Sjobeck M., Ghebremedhin E., Englund E. Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int. J. Geriatr. Psychiatry 2006, 21:681-687.
130. Suter O.C., Sunthorn T., Kraftsik R., Straubel J., Darekar P., Khalili K., Miklossy J. Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 2002, 33:1986-1992.
131. Henon H., Durieu I., Guerouaou D., Lebert F., Pasquier F., Leys D. Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 2001, 57:1216-1222.
132. Kalaria R.N., Ihara M. Dementia: vascular and neurodegenerative pathways-will they meet?. Nat. Rev. Neurol. 2013, 9:487-488.
133. Pantoni L., Sarti C., Alafuzoff I., Jellinger K., Munoz D.G., Ogata J., Palumbo V. Postmortem examination of vascular lesions in cognitive impairment: a survey among neuropathological services. Stroke 2006, 37:1005-1009.
134. Yoon C.W., Shin J.S., Kim H.J., Cho H., Noh Y., Kim G.H., Chin J.H., Oh S.J., Kim J.S., Choe Y.S., Lee K.H., Lee J.H., Seo S.W., Na D.L. Cognitive deficits of pure subcortical vascular dementia vs. Alzheimer disease: PiB-PET-based study. Neurology 2013, 80:569-573.
135. Maruyama M., Shimada H., Suhara T., Shinotoh H., Ji B., Maeda J., Zhang M.R., Trojanowski J.Q., Lee V.M., Ono M., Masamoto K., Takano H., Sahara N., Iwata N., Okamura N., Furumoto S., Kudo Y., Chang Q., Saido T.C., Takashima A., Lewis J., Jang M.K., Aoki I., Ito H., Higuchi M. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 2013, 79:1094-1108.
136. Teuschl Y., Matz K., Brainin M. Prevention of post-stroke cognitive decline: a review focusing on lifestyle interventions. Eur. J. Neurol. 2013, 20:35-49.
137. Moroney J.T., Bagiella E., Tatemichi T.K., Paik M.C., Stern Y., Desmond D.W. Dementia after stroke increases the risk of long-term stroke recurrence. Neurology 1997, 48:1317-1325.
138. Akinyemi R.O., Mukaetova-Ladinska E.B., Attems J., Ihara M., Kalaria R.N. Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia. Curr. Alzheimer Res. 2013, 10:642-653.
139. Douiri A., McKevitt C., Emmett E.S., Rudd A.G., Wolfe C.D. Long-term effects of secondary prevention on cognitive function in stroke patients. Circulation 2013, 128:1341-1348.
140. Rothwell P.M., Giles M.F., Chandratheva A., Marquardt L., Geraghty O., Redgrave J.N., Lovelock C.E., Binney L.E., Bull L.M., Cuthbertson F.C., Welch S.J., Bosch S., Alexander F.C., Silver L.E., Gutnikov S.A., Mehta Z. Early use of existing preventive strategies for stroke, effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007, 370:1432-1442.
141. Wright J.M., Musini V.M. First-line drugs for hypertension. Cochrane Database Syst. Rev. 2009, CD001841.
142. P.C.Group Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358:1033-1041.
143. Jacquin A., Aboa-Eboule C., Rouaud O., Osseby G.V., Binquet C., Durier J., Moreau T., Bonithon-Kopp C., Giroud M., Bejot Y. Prior transient ischemic attack and dementia after subsequent ischemic stroke. Alzheimer Dis. Assoc. Disord. 2012, 26:307-313.
144. Lin J.H., Lin R.T., Tai C.T., Hsieh C.L., Hsiao S.F., Liu C.K. Prediction of poststroke dementia. Neurology 2003, 61:343-348.
145. Gregoire S.M., Smith K., Jager H.R., Benjamin M., Kallis C., Brown M.M., Cipolotti L., Werring D.J. Cerebral microbleeds and long-term cognitive outcome: longitudinal cohort study of stroke clinic patients. Cerebrovasc. Dis. 2012, 33:430-435.
146. Goldstein L.B., Bushnell C.D., Adams R.J., Appel L.J., Braun L.T., Chaturvedi S., Creager M.A., Culebras A., Eckel R.H., Hart R.G., Hinchey J.A., Howard V.J., Jauch E.C., Levine S.R., Meschia J.F., Moore W.S., Nixon J.V., Pearson T.A., C.American Heart Association Stroke, N.Council on Cardiovascular, E.Council on, Prevention, R.Council for High Blood Pressure, D.Council on Peripheral Vascular, C.Interdisciplinary Council on Quality of, R.Outcomes Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:517-584.
147. Amarenco P., Lavallee P., Touboul P.J. Stroke prevention, blood cholesterol, and statins. Lancet Neurol. 2004, 3:271-278.
148. Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto A.M., Kastelein J.J., Koenig W., Libby P., Lorenzatti A.J., MacFadyen J.G., Nordestgaard B.G., Shepherd J., Willerson J.T., Glynn R.J., Group J.S. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 2008, 359:2195-2207.
149. Homocysteine Studies C. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002, 288:2015-2022.
150. Rowan E.N., Dickinson H.O., Stephens S., Ballard C., Kalaria R., Kenny R.A. Homocysteine and post-stroke cognitive decline. Age Ageing 2007, 36:339-343.
151. Kurella Tamura M., Wadley V., Yaffe K., McClure L.A., Howard G., Go R., Allman R.M., Warnock D.G., McClellan W. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am. J. Kidney Dis. 2008, 52:227-234.
152. Traylor M., Farrall M., Holliday E.G., Sudlow C., Hopewell J.C., Cheng Y.C., Fornage M., Ikram M.A., Malik R., Bevan S., Thorsteinsdottir U., Nalls M.A., Longstreth W., Wiggins K.L., Yadav S., Parati E.A., Destefano A.L., Worrall B.B., Kittner S.J., Khan M.S., Reiner A.P., Helgadottir A., Achterberg S., Fernandez-Cadenas I., Abboud S., Schmidt R., Walters M., Chen W.M., Ringelstein E.B., O'Donnell M., Ho W.K., Pera J., Lemmens R., Norrving B., Higgins P., Benn M., Sale M., Kuhlenbaumer G., Doney A.S., Vicente A.M., Delavaran H., Algra A., Davies G., Oliveira S.A., Palmer C.N., Deary I., Schmidt H., Pandolfo M., Montaner J., Carty C., Bakker P.I.de, Kostulas K., Ferro J.M., Zuydam N.R.van, Valdimarsson E., Nordestgaard B.G., Lindgren A., Thijs V., Slowik A., Saleheen D., Pare G., Berger K., Thorleifsson G., Hofman A., Mosley T.H., Mitchell B.D., Furie K., Clarke R., Levi C., Seshadri S., Gschwendtner A., Boncoraglio G.B., Sharma P., Bis J.C., Gretarsdottir S., Psaty B.M., Rothwell P.M., Rosand J., Meschia J.F., Stefansson K., Dichgans M., Markus H.S., C.International Stroke Genetics Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 2012, 11:951-962. W.T.C.C.C. Australian Stroke Genetics Collaborative.
153. Holliday E.G., Maguire J.M., Evans T.J., Koblar S.A., Jannes J., Sturm J.W., Hankey G.J., Baker R., Golledge J., Parsons M.W., Malik R., McEvoy M., Biros E., Lewis M.D., Lincz L.F., Peel R., Oldmeadow C., Smith W., Moscato P., Barlera S., Bevan S., Bis J.C., Boerwinkle E., Boncoraglio G.B., Brott T.G., Brown R.D., Cheng Y.C., Cole J.W., Cotlarciuc I., Devan W.J., Fornage M., Furie K.L., Gretarsdottir S., Gschwendtner A., Ikram M.A., Longstreth W.T., Meschia J.F., Mitchell B.D., Mosley T.H., Nalls M.A., Parati E.A., Psaty B.M., Sharma P., Stefansson K., Thorleifsson G., Thorsteinsdottir U., Traylor M., Verhaaren B.F., Wiggins K.L., Worrall B.B., Sudlow C., Rothwell P.M., Farrall M., Dichgans M., Rosand J., Markus H.S., Scott R.J., Levi C., Attia J., C.Australian Stroke Genetics, C.International Stroke Genetics, C.Wellcome Trust Case Control Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat. Genet. 2012, 44:1147-1151.
154. Sharma P., Yadav S., Meschia J.F. Genetics of ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 2013, 84:1302-1308.
155. Lindgren A. Stroke genetics: a review and update. J. Stroke 2014, 16:114-123.
156. Kilarski L.L., Achterberg S., Devan W.J., Traylor M., Malik R., Lindgren A., Pare G., Sharma P., Slowik A., Thijs V., Walters M., Worrall B.B., Sale M.M., Algra A., Kappelle L.J., Wijmenga C., Norrving B., Sandling J.K., Ronnblom L., Goris A., Franke A., Sudlow C., Rothwell P.M., Levi C., Holliday E.G., Fornage M., Psaty B., Gretarsdottir S., Thorsteinsdottir U., Seshadri S., Mitchell B.D., Kittner S., Clarke R., Hopewell J.C., Bis J.C., Boncoraglio G.B., Meschia J., Ikram M.A., Hansen B.M., Montaner J., Thorleifsson G., Stefanson K., Rosand J., Bakker P.I.de, Farrall M., Dichgans M., Markus H.S., Bevan S., C.the International Stroke Genetics Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology 2014, 83:678-685. W.T.C.C.C.A.S.G.C.t.M.C. Garnet Collaborative Research Group.
157. Haffner C., Malik R., Dichgans M. Genetic factors in cerebral small vessel disease and their impact on stroke and dementia. J. Cereb. Blood Flow Metab. 2015.
158. Network N.S.G., C.International Stroke Genetics Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study. Lancet Neurol. 2015.
159. Kalimo H., Kalaria R.N. Hereditary forms of vascular dementia. Cerebrovascular Diseases, Pathology & Genetics 2005, 5:324-384. ISN Neuropath Press, Basel. H. Kalimo (Ed.).
160. Hara K., Shiga A., Fukutake T., Nozaki H., Miyashita A., Yokoseki A., Kawata H., Koyama A., Arima K., Takahashi T., Ikeda M., Shiota H., Tamura M., Shimoe Y., Hirayama M., Arisato T., Yanagawa S., Tanaka A., Nakano I., Ikeda S., Yoshida Y., Yamamoto T., Ikeuchi T., Kuwano R., Nishizawa M., Tsuji S., Onodera O. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N. Engl. J. Med. 2009, 360:1729-1739.